Companies / Germany
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Bayer Cuts Workforce
March 2007 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
German drugmaker Bayer has announced that as part of its recently completed acquisition of local rival Schering AG , it will be reducing its workforce by 6,100, with 3,150 of these jobs being lost in Europe. This is the latest example of the trend towards restructuring that is sweeping the drug industry. As the operating environment intensifies, multinational drugmakers are looking to cut costs as a way of maintaining profit and growth targets.